Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–70
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants in Groups B and C will be classified by renal function by eGRF at screening and confirmed on Day -1
Participants in Group A will be healthy participants as determined by no significant deviations in normal medical and surgical history and assessments
Participants in Group A must have a body mass index of 18.0 to 32.0 kg/m2, inclusive
Females must be of non-childbearing potential
You may not be if
Participants in Groups B and C cannot have an indwelling catheter for hemodialysis
Participants in Groups B and C cannot have had, nor be waiting for, an organ transplant
Clareo Health | Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment
